Medium Biosciences
AI-designed Affinity Reagents
What they do
Researchers and diagnostic developers need high-performance affinity reagents quickly, but traditional development takes months.
The company uses AI and protein design to create and experimentally validate custom affinity reagents within weeks.
Research teams and diagnostic developers who require validated molecular affinity reagents.
Founders
MIT Computer Science and Electrical Engineering alum with a focus in machine learning and protein design. I'm particularly interested in applications in industrial chemicals, drug development, and agriculture. Working on Medium Biosciences to accelerate protein design 🚀
Studied CS & AI at MIT. Published 8 papers across LLMs, computer vision, and protein design. Now: AI & protein design → reagents
Company timeline
- Founded2021
- YC batchSummer 2021
- StatusActive
- Team size6 people
- LocationSan Francisco, CA, USA
Similar startups
